Pharmaceutical and Biotech Digital Transformation Conference

November 6-7, 2019 | Philadelphia, PA

Penn's View Hotel

Download AgendaRegister Now

DAY TWO | THURSDAY, NOVEMBER 7

8:15 REGISTRATION & COFFEE

8:45 CHAIRPERSON’S OPENING REMARKS
Kimberly Gold, Partner, REED SMITH LLP

9:00 PANEL – RATIONALE FOR UNVEILING PATIENT EXPERIENCE VIA DIGITAL MEANS

  • Outlining the “consumer experience” in pharma
  • Rationale for optimization via digital means
  • Applying user-experience and behavior analytics
  • Consumer knowledge strategies from other industries

MODERATOR: Amir Lahav, FORMERLY AT PFIZER

PANELISTS:
Pranay Sinha, ORTHO-CLINICAL DIAGNOSTICS

Supriya Lagu, Digital Transformation Professional

Michael Song, ASTRAZENECA

 

9:45 BREAKOUT DISCUSSION: EXCHANGE OF INNOVATIVE DIGITAL TRENDS AND CHALLENGES
During this interactive session, participants will engage in peer to peer discussion and dive into focused topics related to specific digital transformation innovations. Gathering with peers interested in similar inventive opportunities, each discussion group will provide invaluable insights into cutting-edge technologies and strategies applicable to digital efforts. All participants are given the opportunity to select a topic among those listed below to explore in a group led by an industry leader who will report key findings to the rest of the audience at the end of the session, maximizing all participants’ number of take-home messages.

  • GROUP 1: 3D printing pill doses
    Shaheen Lakhan, SAGE THERAPEUTICS
  • GROUP 2: AI for drug discovery
  • Nishtha Gupta, GLAXOSMITHKLINE

 

10:30 COFFEE & NETWORKING BREAK

 

11:00 PANEL – OUTSIDE INDUSTRY PERSPECTIVE: EXPLORING SUCCESSFUL DIGITAL INNOVATION MODELS

  • Opportunities and limitations of an all-digital model
  • Continuous improvement via consumer data analysis
  • Approaches to optimizing the user-experience
  • ROI achievements via the use of digital technology
  • Future projections of digital innovation efforts

MODERATOR: Kimberly Gold, REED SMITH LLP

PANELISTS: Ozge Kurtoglu, PEARSON

Anna Kravets, ADIRA LLC

 

11:45 BREAKOUT DISCUSSION: EXPANDING DIGITAL INITIATIVES INTO DISTINCT CORPORATE TEAMS
With digital initiatives developing rapidly and expanding across teams within pharmaceutical and biotech organizations, it is necessary to deeply explore how to effectively apply promising technology to diverse departments and ultimately optimize operations. Digitally transforming manufacturing processes, clinical affairs or commercial and marketing activities however present specific challenges to be considered upfront in order to efficiently develop a robust strategy and lead the project to successful completion. This session enables peer-to-peer exchange of practical information and lessons learned focused on leading digital endeavors within a distinct function, through facilitated small group discussions for the audience to select and actively participate in.

  • GROUP 1: Clinical
    Nishtha Gupta, GLAXOSMITHKLINE
  • GROUP 2: Commercial & Marketing
    Pranay Sinha, ORTHOCLINICAL DIAGNOSTICS
  • GROUP 3: Manufacturing
    Vik Sharma, formerly at PFIZER

 

12:30 LUNCHEON FOR ALL PARTICIPANTS

 

1:30 INDUSTRY CASE STUDY – GENERATING GREATER PATIENT CONNECTIVITY THROUGH DIGITAL ENGAGEMENT
With data integration efforts taking place across the organization, it is essential for patient centricity to be addressed through new and innovative digital efforts which meet the needs of patients. Through productive digital engagement efforts, pharmaceutical and biotech professionals access greater patient data and gain a more defined understanding of ongoing patient behavior and needs. Engaging with patients through digital tools also positions industry leaders to effectively digitize and utilize the data gathered, create central access among teams, and successfully drive digital transformation initiatives around patient engagement.

  • Development of digital patient engagement strategy
  • Varied methods & channels of digital patient engagement
  • Data collection, analysis & perspective on consumer privacy
  • Challenges encountered & overcome in digital connections

Amir Lahav, Digital Transformation Consultant, FORMERLY AT PFIZER

 

2:15 EXPLORATION OF ROI MEASUREMENT STRATEGIES FOR DIGITAL TRANSFORMATION INITIATIVES

  • Evaluation of immediate metrics vs. longer timelines
  • Assessment of human factors impact on ROI
  • Demonstrating positive outcomes of digital initiatives

Michael Senical, Corporate Strategy and Innovation, ASTELLAS PHARMA US

 

3:00 MAINTAINING COMPLIANCE WITH DATA PRIVACY RULES IN THE US AND EUROPE

  • Analysis of secure data collection methods
  • HIPAA and further US data protection rules
  • Ensuring compliance with the EU GDPR
  • Continued improvement in software analytics

Kimberly Gold, Partner, REED SMITH LLP

 

3:45 CLOSING REMARKS & CONFERENCE CONCLUSION

2019 Pharmaceutical and Biotech Digital Transformation Conference Banner

Download the Agenda

We hope to see you at the conference!

Share This